Quarterly report pursuant to Section 13 or 15(d)

EARNINGS PER SHARE (Details)

v3.22.2.2
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 4 Months Ended 5 Months Ended 9 Months Ended
Jun. 30, 2021
May 17, 2021
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2021
May 17, 2021
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                    
Net (loss) income $ (209,586) $ 242,214 $ (18,472) $ 256,580 $ (491,975) $ (461,313) $ 8,780 $ (670,899) $ 250,994 $ (253,867)
Dividends on preferred stock     (1,309)     (2,095)   (3,126) 0 (4,136)
NET (LOSS) INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS     (19,781)     (463,408)   (674,025) 250,994 (258,003)
Net (loss) income attributable to common stockholders, diluted     $ (19,781)     $ (463,408)   $ (674,025) $ 250,994 $ (258,003)
Basic shares (in shares)     19,635,000     20,598,000   20,507,000 160,834,000 20,514,000
Basic EPS (in usd per share)     $ (1.01)     $ (22.50)   $ (32.87) $ 1.56 $ (12.58)
Dilutive EPS (in usd per share)     $ (1.01)     $ (22.50)   $ (32.87) $ 1.56 $ (12.58)
Common Stock                    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                    
Anti-dilutive shares (in shares)           0   0 0 0
Series A Convertible Preferred Stock                    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                    
Anti-dilutive shares (in shares)     3,700,000             3,700,000
Restricted Stock                    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                    
Anti-dilutive shares (in shares)     1,200,000             1,500,000